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Abstract
This study evaluates the effects of a spearmint (/-carvone) and wintergreen oil (methyl salicylate) emulsion (CMSE) on
age 1 landlocked Atlantic salmon Salmo salar sebago (hereafter salmon). Salmon were immersed in either 257 ml/L
CMSE or 75 mg/L tricaine methanesulfonate (MS-222) to induce anesthesia (stage 4), useful for emersion and
noninvasive husbandry procedures, and then salmon were recovered in fresh water. Induction was quicker in the CMSE
group; however, recovery was quicker in the MS-222 group. A second experiment was conducted in which salmon
were immersed in 257 ml/L CMSE for 8.5 min, or 75 mg/L MS-222 for 8.5 min in order to compare electrocardiographs
during deeper anesthesia (stage 5) between salmon continuously immersed in CMSE to those continuously immersed
in MS-222. Because salmon remained sedated longer after CMSE exposure than after MS-222 exposure, a third group of
salmon was immersed in 257 ml/L CMSE for just 2.5 min before undergoing the 6-min electrocardiograph procedure.
Anesthesia induction rates, recovery rates, and electrocardiographs of salmon anesthetized with CMSE were
comparable to salmon anesthetized with MS-222. Salmon anesthetized with CMSE and then transferred immediately to
fresh water had more stable heart rates than salmon anesthetized with either MS-222 or CMSE continuously. Salmon
bathed continuously in CMSE showed clinical signs of increasing anesthetic depth including decreasing heart rate,
decreasing respiration rate and electrocardiograph abnormalities. The CMSE, with its mint and wintergreen
concentrations less than in household products such as chewing gum, toothpaste, and mouthwash, is a potent, rapid-
acting immersion fish anesthetic comparable to MS-222 for stages 4 and 5 anesthesia.
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Introduction
In the United States, no approved fish anesthetic exists
with a 0-d preslaughter drug (allowed to be consumed
by humans on the same day as application of drug)
withdrawal period, nor is there a 0-d preangling fish
anesthetic approved. The U.S. Food and Drug Adminis-
tration (FDA)-approved and commonly used fish anes-
thetic tricaine methanesulfonate (MS-222; Argent Chem-
ical Co., Redmond, WA), has a 21-d preslaughter drug
withdrawal period. Consequently, food fish cannot be
anesthetized within 21 d of slaughter, nor can wild fish
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be anesthetized and released back into public waters
when they might be recaptured and consumed by
anglers during the 21-d drug withdrawal period. An
efficacious fish anesthetic that is safe for 0 d before
slaughter and immediate release after use has been the
goal of state, federal, and private fisheries professionals
for decades (Marking and Meyer 1985; Schnick 2005,
2006). The Aquaculture Association Drug Approval
Partnership (http://www.fws.gov/fisheries/aadap/home.
htm) was formed as an alliance of public and private
fisheries and aquaculture professionals that would target
their limited resources toward more effective aquacul-
ture drug approval in the United States. A top priority of
the Aquaculture Association Drug Approval Partnership
is to find a 0-d preslaughter withdrawal period fish
anesthetic.
Anesthesia is a triad of narcosis, analgesia, and skeletal
muscle relaxation (Brown 1993). A multifarious assort-
ment of off-label drugs and unapproved substances will
anesthetize fishes (Brown 1993; Neiffer 2007). However,
drug residue levels, carcinogenicity, metabolite toxicity,
or the absence of this type of pharmacological informa-
tion has prevented any drug from being FDA approved
for 0-d preslaughter withdrawal. Routes and methods of
delivering a chemical fish anesthetic include immersion;
parenteral, intramuscular, or intraperitoneal injection;
and oral ingestion. Myriad routes and methods of drug
delivery complicate ichthyio-pharmacology and further
stifle FDA approval. Of the anesthetic delivery methods,
immersion is the most common and most practical
means of anesthetizing batches of fish, or fishes, and is
routine procedure in aquaculture and resource fisheries
management (Wedemeyer 2001). Determining drug
residue levels and other pharmacological information
on immersion anesthetics delivered to different fish
species, different fish sizes, and different exposure
durations has proven too costly to drug manufacturers
for a 0Minor Use, Minor Species0 market that is small; the
Minor Use and Minor Species Animal Health Act of 2004,
commonly referred to as the ‘‘MUMS Act,’’ was signed
into law on August 2, 2004 (USFDA 2011). The law is
intended to make more medications legally available to
veterinarians and animal owners to treat minor animal
species, defined as animals other than cattle, horses,
swine, chickens, turkeys, dogs, and cats; and uncommon
diseases in the major animal species (USFDA 2011).
Consequently, the Aquaculture Association Drug Ap-
proval Partnership has stepped in to coordinate Inves-
tigational New Animal Drug and other FDA-approval
steps with manufacturers of potential 0-d preslaughter
withdrawal fish anesthetic compounds. One of these
potential fish anesthetic compounds is an emulsified
mixture of two common human food substances:
spearmint oil (l-carvone) and wintergreen oil (methyl
salicylate).
Spearmint Mentha spicata has been consumed by
humans for millennia; it has been written into mythical
and religious tales, and today mint is the third most
popular flavor in the world behind vanilla Vanilla
planifolia and citrus (Hayes et al. 2007). In antiquity,
spearmint was known as the herb of hospitality (de
Carvalho and Da Fonseca 2006). Today, the world market
for spearmint oil is approximately 1,500 tons/y (Peterson
2004). It is used in cuisine, candy, chewing gum,
cosmetics, toothpaste, tobacco products, and pharma-
ceutical preparations (Chen et al. 2010).
Carvone is the component of the spearmint oil that
gives it a minty fragrance and flavor. Caraway Carum carvi
seeds, dill weed Anethum graveolens, mandarin orange
Citrus reticulata, peels, peppermint Mentha piperita, and
many fruits contain mixtures of both enantiomers of
carvone and related substances that give them their
unique fragrances. l-Carvone can be biosynthesized from
tangerine peels or extracted from spearmint plants (de
Carvalho and Da Fonseca 2006). In the United States,
l-carvone is available from both synthetic and natural
sources (Lawrence 2007). Pharmacologically, l-carvone is
reported to be a sodium channel blocker (de Sousa et al.
2007; Goncalves et al. 2008). l-Carvone’s anesthetic effect
on the peripheral and central nervous systems include
central nervous system depression, antinociceptive ef-
fects, sedation, and anticonvulsant-like activity (de Sousa
et al. 2007; Goncalves et al. 2008; Oliveira et al. 2008).
Wintergreen oil is a natural product of many plants
and is considered to be an antiherbivore defense
compound. Wintergreen oil is used as a rubefacient in
human and veterinary liniments and as a flavoring agent
in cuisine, chewing gum, candy, toothpaste, tobacco
products, and pharmaceutical preparations (USEPA 2005;
Chen et al. 2010). Methyl salicylate is the component of
wintergreen oil that gives it a cool and minty fragrance
and flavor. Methyl salicylate can be synthesized by
esterifying salicylic acid with methanol, but for centuries
it was distilled from twigs of sweet birch Betula lenta and
eastern teaberry Gaultheria procumbens. In the United
States, methyl salicylate is available from both synthetic
and natural sources. It is available Kosher, Halal, and
GMP. Methyl salicylate is purported to be a nonsteroidal
anti-inflammatory drug with pharmacological effects
comparable to salicylic acid (Stevens and Warren 1964).
Salicylate’s pharmacological properties include antinoci-
ceptive effects, anti-inflammatory effects, inhibition of
platelet aggregation, and toxicity (Davison et al. 1961;
Ichiyama et al. 2002; Soo Hoo et al. 2003; Calvo 2006).
Although both l-carvone and methyl salicylate are
capable of anesthetizing fishes individually (data not
shown), the mixture of l-carvone and methyl salicylate is
a superior anesthetic with lower doses, quicker induction
times, quicker recovery times, and less muscle move-
ment in emersed fishes. The synergistic effects of
anesthetic drug combinations are well documented
and form the basis of medical plans for pain manage-
ment (Skarda et al. 1995; West et al. 2007). The
synergistic combination of a nonsteroidal anti-inflamma-
tory drug and Na+ channel blocker are particularly adept
at analgesia of the peripheral nervous system and well
suited for topical application (Liedtke 2006). Based on
the modulated receptor hypothesis, the combination of
a nonsteroidal anti-inflammatory drug and a Na+ channel
blocker enhances anesthesia by increasing the affinity of
Na+ channel blockers with high lipid solubility to
inactivated state Na+ channels (Hiji et al. 1987; Ichikawa
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1987). Salicylate enhances tonic and phasic blocking of
Na+ channels induced by class 1 highly liposoluble
antiarrhythmic agents (Tanaka et al. 1999). The spearmint
(l-carvone) and wintergreen (methyl salicylate) oil emul-
sion (CMSE) label reveals a 7:1 ratio of l-carvone to methyl
salicylate, and it is applied topically to fish by immersion.
The emulsion takes advantage of both the synergistic
effects of a nonsteroidal anti-inflammatory drug paired
with a Na+ channel blocker and their aptitude for
peripheral nerve analgesia when applied topically.
This study determined the induction rate, recovery
rate, and electrocardiograph pattern of fish anesthetized
with a novel l-carvone– and methyl salicylate-based
anesthetic and compared them with the commonly used
FDA-approved fish anesthetic MS-222 (Supplemental
Material, Table S1; http://dx.doi.org/10.3996/032011-
JFWM-025.S1). We report that CMSE is an effective
nonnarcotic, norbarbiturate immersion fish anesthetic




The CMSE (Maine Conservation Medicine Center, Inc.,
Waterville, ME) is composed of 28.4% l-carvone (p-
mentha-6,8-dien-2-one), 4% methyl salicylate (methyl-2-
hydroxybenzoate), 25% glycerin, and 5% polysorbate 80
in an aqueous solution. The ingredients are blended
aggressively until a brilliant white 5-mm micelle emulsion
forms. The liquid anesthetic is dispensed by volume with
1 mL of CMSE containing 75 ml/L l-carvone, 11 ml/L
methyl salicylate, and 300 ml/L emulsifiers (i.e., 86 ml/L of
the combination and 300 ml/L emulsifiers). The stock
solution has a pH of 5.8. The manufacturer’s working
draft FDA drug label was followed with an empirical dose
of 257 ml/L CMSE used to anesthetize landlocked Atlantic
salmon Salmo salar Sebago (hereafter, salmon). The pH of
the anesthetic bath remained at 6.8 after the 30 mL of
CMSE was added to the 38 L of hatchery water in an
anesthetic tank. The immersion anesthetic solution was
not buffered because adjusting the pH of the immersion
solution is not part of the draft label directions for CMSE.
The effect of CMSE on the hatchery water’s pH best fit a
line pH = 0.0107 ml + 6.8 at 12uC.
The MS-222 powder (Argent Chemical Co.) was
weighed on a gram scale. The 75 mg/L dose determined
for the 38-L anesthetic tank was 2.8 g of MS-222. The pH of
the anesthetic bath decreased from 6.8 to 3.7 after the MS-
222 was added. The immersion anesthetic solution was
not buffered because adjusting the pH of the anesthetic
solution is not part of the FDA label directions for MS-222’s
use (Welker et al. 2007). The hatchery-specific effect of MS-
222 on the water’s pH was measured with MS-222
concentrations between 1,000 and 16 mg/L using a pH
meter. The effect of MS-222 on the hatchery water’s pH
best fit a line pH = 0.1179 mg + 3.1 at 12uC.
Subjects
We obtained 130 age 1 salmon (mean body mass 6
SD, 117 6 26 g; mean total body length, 222 6 14 mm)
from the Maine Department of Inland Fisheries and
Wildlife, Ela Fish Rearing Station, Embden, Maine. Salmon
came from a larger lot previously inspected for, and
found negative of, fish pathogens of regulatory concern
(Wiggins 2001; AFS-FHS 2004).
Stage 4 anesthesia experiment
Three replicates of 10 salmon each were netted out of
a 40,000-L circular rearing tank, placed directly into a 38-
L tank of water (pH 6.8 at 12uC with 86% oxygen
saturation, ,10 mg/L salt), and pretreated with 257 ml/L
CMSE. Another three replicates of 10 salmon were
anesthetized with 75 mg/L MS-222 at the same initial
water temperature, pH, oxygen saturation, and salinity.
Salmon were observed for their reaction to the
anesthetic solution, and the time to stage 4 anesthesia
was recorded for the first and last fish in each replicate.
Salmon were considered handleable when they reached
stage 4 anesthesia (i.e., loss of equilibrium, no effort to
right itself, decreased muscle tone, some reaction to
strong stimuli; Brown 1993). Fish were weighed, mea-
sured, and transferred into 38 L of fresh untreated water
for recovery. Because the 10 fish in each replicate did not
induce and recover synchronously, the time to recovery
was recorded for the first and last fish in each replicate.
Salmon were considered recovered when they returned
to normal (i.e., righted itself, swim actively, muscle tone
normal; Brown 1993). A mean time to stage 4 anesthesia
and a mean time to recovery were calculated between
the first and last fish in each replicate. Salmon were
monitored for survival for 14 d.
Stage 5 anesthesia experiment
Sixty salmon were randomly assigned to one of three
treatment groups to compare the effects of either brief
CMSE exposure (CMSE-FW) or continuous CMSE expo-
sure (CMSE-CE) on a salmon’s electrocardiograph (ECG)
and the effects of continuous MS-222 exposure (MS-222-
CE) on a salmon’s ECG. Salmon were anesthetized in the
38-L tanks as described under Stage 4 anesthesia
experiment. The time to light anesthesia (stage 5,
Table 1) was recorded and standardized to 2.5 min for
all three treatment groups based on our previous
experience with CMSE and MS-222 (Brown 1993). Label
directions for MS-222 state that fish may be left in the
anesthetic solution during procedures for up to 14 min.
There are no directions for euthanasia of fishes with MS-
222; this is an off-label use of MS-222 (Smit and Hattingh
1979; MacAvoy and Zaepfel 1997).
Salmon in the first treatment group (n = 20), CMSE-
FW, were immersed in 257 ml/L CMSE for 2.5 min and
then immediately transferred to fresh water for the
ECG procedure. Salmon in the second treatment group
(n = 20), CMSE-CE, were immersed in 257 ml/L CMSE
continuously for the duration of the ECG procedure.
Salmon in the third treatment group (n = 20), MS-222-
CE, were immersed in 75 mg/L MS-222 continuously for
the duration of the ECG procedure. To control for
treatment effects of the invasive procedure, salmon in
each treatment group were anesthetized in pairs. One
salmon in each pair underwent the ECG procedure, and
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the other control cohort was anesthetized and recovered
but did not undergo the invasive procedure.
ECG procedure
The ECG procedure began without delay after the
salmon were immersed in the anesthetic for 2.5 min.
Salmon were netted out of the anesthetic tank and
placed in dorsal recumbency on a wet sponge sling
partially submerged in either fresh water (CMSE-FW) or
anesthetic solution (CMSE-CE and MS-222-CE). Each
salmon was positioned at a slightly negative incline so
that the head and gills would remain submerged but the
ECG electrodes, belly, and tail would not be submerged
(Figure 1). Two 12-mm, 29-gauge needle electrodes (AD
Instruments, Inc., Colorado Springs, CO) were positioned
in the muscle tissue around the pericardial cavity to
record the heart’s electrical activity; a third grounding
electrode was placed in the hypaxial muscles of the
caudal belly area. The electrodes were positioned as
described by Cotter and Rodnick (2006, 2007). The
needle electrodes were connected to an ECG amplifier
(PowerLab/4ST Bio Amp; AD Instruments, Inc.), computer
(Imac 4.1; Apple, Inc., Cupertino, CA), operating system
(OS X, version 10.4.11; Apple, Inc.), and ECG software
(Chart software, version 5.5; AD Instruments, Inc.). A
separate push button switch was connected to the ECG
amplifier to record respiratory effort. No attempt to
artificially irrigate the gills beyond keeping them
submerged was allowed so that autogenous buccal
pumping efforts could be recorded. The ECG and
respiration rate were recorded for 6 min, after which
the electrodes were removed and the salmon were
transferred into a fresh water recovery tank (pH 6.8 at
12uC, 38 L with 86% oxygen saturation). Recovery time
was recorded. Control cohorts from each pairing were
removed from the treatment tank and placed in fresh
water to begin their recovery period at the same instant
as the electrocardiographed salmon. Fish were moni-
tored for 14 d after the procedure for signs of
postprocedural morbidity or mortality. Separate sponges
were used for CMSE-FW, CMSE-CE and MS-222-CE
treatment groups to prevent cross-contamination from
the different anesthetics.
Statistics
Data were tested for normality using the Shapiro–Wilk
test and normality plots. Means, standard deviations, and
standard errors were calculated for normal data distribu-
tions. Nonparametric tests were chosen for nonnormal
data. Levene’s test was used to test the assumption of
equal variances between groups. Values reported to
determine differences amongst groups were calculated
using statistical Analyze It software (Analyze It, Inc., Leeds,
England, United Kingdom) and Systat 12 software (Systat
Software, Inc., Chicago, IL). Values for heartbeat segments
such as QRS duration, QRS amplitude, and QT duration
data for ECG parameters and respiration rates were
measured directly from individual ECG files within the
ECG software using cardiac parameters described by
Cotter and Rodnick (2006, 2007). A 20-s interval was
selected from each minute of the 6-min ECG procedure to
measure the heart rate. Three individual QRST complexes
were measured for QRS amplitude, QRS duration, and QT
duration from each corresponding 20-s interval of the
matching minute (Supplemental Material, Figure S1; http://
dx.doi.org/10.3996/032011-JFWM-025.S1).
Table 1. Anesthetic stages, descriptions, and fish behaviors associated with each anesthetic stage. Table modified from Cotter
and Rodnick (2006).
Stage Descriptor Fish behavior
0 Unanesthetized and recovered Normal Reactive to stimuli; opercular rate appropriate for species,
water temperature and oxygen saturation, muscle tone
firm; equilibrium normal.
1 Light sedation Handleable (noninvasive
procedures)
Slight loss of reactivity to tactile stimuli;
opercular rate decreased slightly;
equilibrium normal.
2 Deep sedation Total loss of reactivity to weak stimuli, reactive to only very
strong stimuli; opercular rate decreased or increased
slightly; equilibrium normal.
3 Partial loss of equilibrium Reactive only to very strong stimuli; increased or decreased
opercular rate; partial loss of muscle tone; erratic
swimming and disequilibrium.
4 Loss of equilibrium Surgical (invasive procedures) Slow, regular opercular movements;
total loss of equilibrium
and muscle tone.
5 Loss of reflex reactivity Total loss of reactivity to tail pinch;
opercular movements slow;
heart rate slow.
6 Medullary collapse Opercular movements stop, usually
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Results
Salmon anesthetized with CMSE displayed more
excitability before induction than MS-222–anesthetized
salmon. These salmon displayed protective behaviors,
such as flaring opercula, coughing, and anxious swim-
ming and splashing, when immersed in the CMSE
anesthetic bath. The anxious behavior was short-lived
but nevertheless a noteworthy observational difference
between CMSE and MS-222 anesthetic induction.
Salmon anesthetized in CMSE reached stage 4
anesthesia in as quickly as 54 s; the time (mean 6 SE)
to this anesthetic level for the three replicate groups was
1.2 6 0.1 min (Supplemental Material, Table S2; http://dx.
doi.org/10.3996/032011-JFWM-025.S1). Salmon anesthe-
tized in MS-222 reached stage 4 anesthesia as quickly as
1.1 min; the time to this anesthetic level for the three
replicate groups was 1.7 6 0.2 min (Figure 2). Therefore,
CMSE had a slightly quicker induction time to stage 4
anesthesia than MS-222. The difference in mean time to
stage 4 anesthesia between the CMSE and MS-222 was
statistically significant (t = 5.1, df = 8, P , 0.01). Stage 4
anesthesia was adequate for noninvasive routine aqua-
culture and fisheries procedures (e.g., grading, sorting,
spawning, and measuring total body mass and total
body length). The difference in induction time for stage 4
anesthesia between CMSE and MS-222 is not due to
differences in fish size. Total body mass and length were
normally distributed. Student’s independent t-tests
showed no statistical difference in either total body
mass (t = 1.67, df = 58, P = 0.10) or length (t = 0.32, df
= 58, P = 0.75) between salmon anesthetized with CMSE
or MS-222.
Salmon recovered from CMSE anesthesia as fast as
1.5 min after transfer from CMSE to fresh water, and the
mean recovery time for the three replicate groups was 2.5
6 0.4 min. The longest recovery time for any CMSE-
anesthetized salmon was 3.6 min. Salmon recovered to an
upright position within 1.1 min after transfer from MS-222
to fresh water, and the mean recovery time for the three
replicate groups was 2.1 6 0.3 min (Figure 2). Therefore,
CMSE had a slower recovery time from stage 4 anesthesia
than MS-222. The difference in mean recovery time from
stage 4 anesthesia between the CMSE and MS-222 was
statistically significant (t = 3.62, df = 8, P , 0.01). These
findings demonstrate that CMSE has comparable induc-
tion and recovery times (stage 4 anesthesia) to MS-222.
For salmon anesthetized at stage 5, survival rate was
comparable among all treatments, and there was no
statistical difference in survival between any of the six
cohorts (Pearson’s x2 = 0.04, df = 2, P = 0.98;
Supplemental Material, Table S3; http://dx.doi.org/10.
3996/032011-JFWM-025.S1). The CMSE-FW treatment
group had 100% survival in both the anesthesia-only
cohort and the anesthesia-ECG cohort. The CMSE-CE
treatment group had 70% survival in the anesthesia-only
cohort and 70% survival in the anesthesia-ECG cohort.
The MS-222-CE treatment group had 90% survival in the
anesthesia-only cohort and 80% survival in the anesthesia-
ECG cohort.
Figure 1. Landlocked Atlantic salmon Salmo salar sebago being positioned for electrocardiograph procedure. Needle electrodes
were placed in muscle tissue surrounding pericardial cavity. Salmon remained partially submerged in water to keep gills moist; no
additional gill irrigation was provided. Salmon were restrained only by anesthetic and held in dorsal recumbency position by a
trough cut into the sponge.
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Recovery times for salmon recovering from stage 5
anesthesia were not significantly longer than salmon
recovering from stage 4 anesthesia. The mean recovery
times for anesthesia-only cohorts from CMSE-FW,
CMSE-CE, and MS-222-CE were 4.3 6 0.5, 7.5 6 0.5,
and 3.4 6 0.5 min, respectively.
The heart rates in the treatment groups were
comparable and not significantly different (Levene’s test:
F2,27 = 0.26, P = 0.77; Supplemental Material, Table S4;
http://dx.doi.org/10.3996/032011-JFWM-025.S1). The mean
heart rates for the ECG procedure were CMSE-FW = 38 6
2 beats/min, CMSE-CE = 306 2 beats/min, and MS-222-CE
= 33 6 2 beats/min (Figure 3; Table 2). Notwithstanding,
the heart rates of CMSE-CE and MS-222-CE significantly
decreased with time, whereas the heart rate of CMSE-FW
remained stable (Kruskal–Wallis test: CMSE-CE = 17.6, df =
5, P = 0.0035; MS-222-CE = 25.4, df = 5, P , 0.01; CMSE-
FW = 3.87, df = 5, P = 0.56).
The QRS amplitudes in the treatment groups were
comparable and not significantly different. The mean
QRS amplitudes were CMSE-FW = 0.48 6 0.04 mV,
CMSE-CE = 0.55 6 0.30 mV, and MS-222-CE = 0.59 6
0.03 mV (Table 2). In addition, the QRS durations were
comparable and not significantly different among the
treatment groups. The mean QRS durations were CMSE-
FW = 0.18 6 .02 s, CMSE-CE = 0.17 6 0.01 s, and MS-
222-CE = 0.13 6 0.01 s (Table 2). However, the mean QT
duration of CMSE-CE was significantly higher than the
comparable values for CMSE-FW and MS-222-CE (Levine’s
test: F2,27 = 5.51, P = 0.01). The mean QT durations were
CMSE-FW = 0.58 6 .01 s, CMSE-CE = 0.69 6 0.01 s, and
MS-222-CE = 0.576 0.02 s (Figure 4; Table 2). Moreover,
QT durations of CMSE-CE and MS-222-CE showed
significant variation during the duration of the ECG
procedure (Kruskal–Wallis test: CMSE-CE = 11.5, df = 5,
P = 0.04; MS-222-CE = 20.7, df = 5, P , 0.01) but this
duration was not significant for CMSE-FW (0.61, df = 5,
P = 0.99).
Respiration rates
The respiration rate of salmon was significantly
reduced by CMSE-CE and CMSE-FW (hypopnea) and
increased (tachypnea) by MS-222-CE (Levine’s test: 13.37,
df = 2, P , 0.01; Supplemental Material, Table S4; http://
dx.doi.org/10.3996/032011-JFWM-025.S1). Before anes-
thesia, the respiration rate of salmon was 80 buccal
pumps/min (pH 6.8, 12uC, 86% oxygen saturation,
,10 mg/L salt). The respiration rate of CMSE-FW–
anesthetized salmon was 15.2 6 7 buccal pumps/min,
of CMSE-CE–anesthetized salmon was 2.5 6 1 buccal
pumps/min, and of MS-222-CE–anesthetized salmon was
143.1 6 63 buccal pumps/min (Table 2).
Discussion
In this study, we found CMSE to be an effective immersion
fish anesthetic. Salmon were rapidly anesthetized with CMSE
Figure 2. Anesthesia induction and recovery times for landlocked Atlantic salmon Salmo salar sebago anesthetized to stage 4
anesthesia (i.e., loss of equilibrium, no effort to right itself, decreased muscle tone, some reaction to strong stimuli; Brown 1993) with
spearmint (l-carvone) and wintergreen (methyl salicylate) oil emulsion fish anesthetic or tricaine methanesulfonate fish anesthetic.
Salmon were considered handleable when they reached stage 4 anesthesia.
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Figure 3. Heart rate (mean 6 SE) of landlocked Atlantic salmon Salmo salar sebago exposed to an anesthetic for 2.5 min of
induction to stage 5 anesthesia (i.e., loss of reactivity to tail pinch; opercular movements slow; heart rate slow; Brown 1993) and then
attached to an electrocardiograph (ECG) for six additional minutes. Salmon anesthetized in tricaine methanesulfonate (MS-222)
remained in the anesthetic solution during the ECG procedure (MS-222-CE). A second group of salmon anesthetized with the
spearmint (l-carvone) and wintergreen (methyl salicylate) oil emulsion (CMSE) fish anesthetic remained in the anesthetic solution
during the ECG procedure (CMSE-CE), whereas the third group of CMSE–anesthetized salmon was transferred into fresh water for the
ECG procedure (CMSE-FW).
Table 2. Average per minute values (mean 6 SE) for heart rate, QRS amplitude, QRS duration, and QT duration recorded during
the electrocardiograph (ECG). Salmon anesthetized in tricaine methanesulfonate (MS-222) remained in the anesthetic solution
during the ECG (MS-222-CE). Landlocked Atlantic salmon Salmo salar sebago were induced to stage 5 anesthesia (i.e., loss of
reactivity to tail pinch; opercular movements slow; heart rate slow; Brown 1993) with spearmint (l-carvone) and wintergreen (methyl
salicylate) oil emulsion (CMSE) fish anesthetic or MS-222 for 2.5 min before beginning the ECG. One group of salmon anesthetized
with CMSE remained in the anesthetic solution during the ECG procedure (CMSE-CE), whereas the other group of CMSE-
anesthetized salmon was transferred into fresh water for the ECG procedure (CMSE-FW).
Parameter (units) Group n
Avg. for each min during ECG (mean ± SE)
Avg.1 2 3 4 5 6
Heart rate (beats/min) CMSE-FW 10 38 6 6 36 6 5 30 6 3 40 6 5 42 6 5 41 6 7 38 6 2
CMSE-CE 10 44 6 4 37 6 5 28 6 3 26 6 3 21 6 2 26 6 2 30 6 2
TMS-CE 10 55 6 5 37 6 5 28 6 2 26 6 2 24 6 2 26 6 2 33 6 2
QRS amplitude (mV) CMSE-FW 10 0.64 6 0.15 0.52 6 0.13 0.47 6 0.10 0.49 6 0.12 0.45 6 0.09 0.34 6 0.03 0.48 6 0.04
CMSE-CE 10 0.69 6 0.11 0.55 6 0.10 0.54 6 0.10 0.52 6 0.09 0.51 6 0.10 0.52 6 0.10 0.55 6 0.04
TMS-CE 10 0.65 6 0.09 0.59 6 0.07 0.58 6 0.08 0.56 6 0.09 0.60 6 0.10 0.55 6 0.09 0.59 6 0.03
QRS duration (s) CMSE-FW 10 0.20 6 0.06 0.18 6 0.06 0.20 6 0.06 0.20 6 0.04 0.16 6 0.03 0.12 6 0.02 0.18 6 0.02
CMSE-CE 10 0.24 6 0.04 0.16 6 0.02 0.17 6 0.02 0.16 6 0.02 0.17 6 0.02 0.14 6 0.02 0.17 6 0.01
TMS-CE 10 0.11 6 0.02 0.13 6 0.03 0.13 6 0.03 0.13 6 0.04 0.15 6 0.04 0.13 6 0.04 0.13 6 0.01
QT duration (s) CMSE-FW 10 0.60 6 0.03 0.59 6 0.04 0.59 6 0.04 0.56 6 0.04 0.57 6 0.04 0.60 6 0.03 0.58 6 0.01
CMSE-CE 10 0.68 6 0.04 0.63 6 0.03 0.69 6 0.03 0.70 6 0.03 0.76 6 0.02 0.72 6 0.03 0.69 6 0.01
TMS-CE 10 0.37 6 0.05 0.58 6 0.04 0.65 6 0.03 0.58 6 0.04 0.61 6 0.03 0.64 6 0.03 0.57 6 0.02
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to stage 4 anesthesia for routine husbandry procedures and
were anesthetized to stage 5 anesthesia for an invasive
procedure. All procedures were accomplished at concentra-
tions of l-carvone and methyl salicylate that are similar to
concentrations of spearmint oil and wintergreen oil found in
human food, candy, chewing gum, tobacco products,
toothpaste, mouthwash, cosmetic products, and approved
pharmaceuticals. Because all of the ingredients in CMSE are
already present in approved pharmaceuticals and the human
food chain, CMSE may provide a solution to overcome the
longstanding challenge of finding a 0-d preslaughter
withdrawal anesthetic for food fish in the United States.
The efficacy of CMSE to anesthetize salmon is an
important disclosure. Salmon are rapidly anesthetized to
stage 4 anesthesia in approximately a minute of
exposure to CMSE. Salmon remain anesthetized for
several minutes after immersion when transferred into
fresh water for human handling. This effect is advanta-
geous for husbandry procedures that transfer batches of
anesthetized fish to fresh water and thus prevents direct
exposure of handlers to the anesthetic solution. The
spearmint and wintergreen oil emulsion has potential as
an immersion anesthetic for other salmonid species and
many other cold-, cool-, and warm-water fishes that are
important human food animals.
Salmon were anesthetized for an invasive ECG
procedure with CMSE to assess the characteristics of
stage 5 anesthesia achieved as well as the effects on the
salmon heart’s electrical activity. Salmon induced with
CMSE and then transferred into fresh water for the ECG
remained anesthetized for at least 6 min survived the
procedure and had a stable heart rate, ECG pattern, and
respiratory rate (Figure 3) and recovered without mor-
tality. The effects of CMSE on salmon acid–base balance,
hematocrit, blood gases and osmolality, and cortisol and
adrenaline levels need to be determined. Salmon
induced with CMSE and then kept in the CMSE solution
during the ECG procedure progressed to deeper
anesthetic depths as evidenced by progressive hypo-
pnea and significant ECG abnormalities. The mortalities
in the CMSE-CE and MS-222-CE study groups were not
statistically significant and might have been due to the
small size of salmon used, the acidic effects of
unbuffered MS-222 used, or the minimal gill irrigation
allowed. Additional studies controlling for these variables
are needed.
Cotter and Rodnick (2006) published a similar ECG
study comparing clove Syzygium aromaticum oil and MS-
222. They were able to keep rainbow trout Oncorhynchus
mykis immersed in either anesthetic solution for the
duration of the ECG procedure without significant
mortality. Cotter and Rodnick (2006) concluded that
clove oil and MS-222 produced similar ECG patterns in
anesthetized rainbow trout and that clove oil would be a
Figure 4. QT duration (mean 6 SE) of landlocked Atlantic salmon Salmo salar sebago exposed to an anesthetic for 2.5 min of
induction to stage 5 anesthesia (i.e., loss of reactivity to tail pinch; opercular movements slow; heart rate slow; Brown 1993) and then
attached to an electrocardiograph (ECG) for six additional minutes. Salmon anesthetized in tricaine methanesulfonate (MS-222)
remained in the anesthetic solution during the ECG procedure (MS-222-CE). One group of salmon anesthetized with the spearmint
(l-carvone) and wintergreen (methyl salicylate) oil emulsion (CMSE) fish anesthetic remained in the anesthetic solution during the
ECG procedure (CMSE-CE), whereas the other group of CMSE–anesthetized salmon was transferred into fresh water for the ECG
procedure (CMSE-FW).
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useful fish anesthetic. In contrast to clove oil and MS-222,
CMSE has a much narrower therapeutic window for
anesthesia beyond which CMSE can be fatal. Because
there is no therapeutic labeled for euthanasia of fishes in
the United States, CMSE potentially fills this gap in
ichthyo-therapeutics as well.
Because the use of CMSE and its components as a fish
anesthetic is not yet approved by the FDA, an FDA
Investigational New Animal Drug (11-855) has been filed
for CMSE as a food fish immersion anesthetic and
euthanasia drug. Overall, CMSE is an effective anesthetic
that is able to create stage 4 anesthesia in approximately
a minute. It also creates and maintains a salmon in stage
5 anesthesia with only 2.5 min of exposure. Once
induced, salmon can be transferred to fresh water for
husbandry or invasive procedures; conveniently, salmon
hold remarkably still and respire infrequently. An
affordable anesthetic, made with readily available food
ingredients and with a therapeutic range spanning
between deep narcosis and fatally toxic, has many
applications in aquaculture and fisheries for husbandry
procedures; transport; and minor invasive procedures,
such as radiotransmitter insertion, tagging, fin clipping
tissue biopsy, and euthanasia. Overall, the combination
of inducing variable levels of anesthesia, the lack of
hypersensitivity or allergy to l-carvone in humans (Worm
et al. 1998; Corazza et al. 2002; Surburg and Panten
2006), and its ergonomically useful features make CMSE a
viable option as a 0-d preslaughter withdrawal and 0-d
preangling, immediate release fish anesthetic.
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Table S3. Comparison of recovery time from stage 5
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Table S4. Data points from heart rate, QRS duration,
QRS amplitude, QT duration, and respiration rate of land-
locked Atlantic salmon Salmo salar sebago exposed to an
anesthetic for 2.5 min of induction to stage 5 anesthesia
(i.e., loss of reactivity to tail pinch; opercular movements
slow; heart rate slow; Brown 1993) and then attached to
an electrocardiograph (ECG) for six additional minutes.
Salmon anesthetized in tricaine methanesulfonate (MS-
222) remained in the anesthetic solution during the ECG
procedure (MS-222-CE). A second group of salmon
anesthetized with the spearmint (l-carvone) and winter-
green (methyl salicylate) oil emulsion fish anesthetic
(CMSE) remained in the anesthetic solution during the
ECG procedure (CMSE-CE), whereas the other group of
CMSE anesthetized salmon was transferred into fresh
water for the ECG procedure (CMSE-FW) as recom-
mended by the CMSE drug label.
Figure S1. A sample electrocardiograph trace illus-
trating four heart beats with QRS amplitude, QRS
duration, and QT duration labeled.
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